Header cover image

Taiwanese (TAIEX) Pharma Industry Analysis

UpdatedJan 18, 2022
DataAggregated Company Financials
Companies46
  • 7D-0.4%
  • 3M-1.5%
  • 1Y13.6%
  • YTD-2.5%

Over the last 7 days, the Pharma industry has remained flat, although notably Bora Pharmaceuticals gained 7.7%. As for the the longer term, the industry is up 14% over the past 12 months.

Industry Valuation and Performance

Has the Taiwanese Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPE
Tue, 18 Jan 2022NT$376.1bNT$76.7bNT$8.5b19x
Thu, 16 Dec 2021NT$392.1bNT$76.7bNT$8.5b18.4x
Sat, 13 Nov 2021NT$364.5bNT$76.1bNT$7.9b17.3x
Mon, 11 Oct 2021NT$348.0bNT$76.0bNT$10.7b18.9x
Wed, 08 Sep 2021NT$354.1bNT$76.0bNT$10.7b18.8x
Fri, 06 Aug 2021NT$368.8bNT$76.0bNT$10.7b21.3x
Mon, 10 May 2021NT$358.3bNT$74.2bNT$12.5b18.7x
Sun, 31 Jan 2021NT$300.3bNT$72.4bNT$8.6b17.1x
Wed, 04 Nov 2020NT$356.2bNT$71.7bNT$6.3b18.5x
Sat, 08 Aug 2020NT$328.7bNT$70.9bNT$5.6b20.6x
Fri, 01 May 2020NT$231.6bNT$70.2bNT$1.8b22.3x
Mon, 03 Feb 2020NT$224.7bNT$69.7bNT$1.3b21.6x
Thu, 07 Nov 2019NT$231.9bNT$69.1bNT$5.9b21.2x
Wed, 31 Jul 2019NT$228.5bNT$73.2bNT$7.4b21.6x
Sat, 04 May 2019NT$226.8bNT$78.9bNT$7.8b21.4x
Tue, 05 Feb 2019NT$217.6bNT$82.6bNT$8.6b19.1x
PE Ratio

19.1x

Total Market Cap: NT$217.6bTotal Earnings: NT$8.6bTotal Revenue: NT$82.6b0%0%0%3 Year10 Year
202020212022

Current Industry PE: Investors are relatively neutral on the industry at the moment, considering it's trading close to its 3-year average PE ratio of 20.1x. It appears they believe that earnings will grow in-line with historical growth rates.

Past Earnings Growth: The earnings for companies in the Pharmaceuticals industry have remained mostly flat over the last three years, while revenues for these companies have declined 2.4% per year. This means that the cost of doing business could be reducing since sales have declined but profits have remained steady.

Industry Trends

Which industries have driven the changes within the Taiwanese Pharma industry?

Pharma-0.41%

Industry PE: Investors are most optimistic about the Pharma industry, which is trading close to its 3-year average PE ratio of 20.1x. This is likely because analysts are expecting annual earnings growth of 34%, which is higher than its past year's earnings decline of 11% per year.

Forecasted Growth: Analysts are most optimistic on the Pharma industry, expecting annual earnings growth of 34% over the next 5 years. This is better than its past earnings decline of 11% per year.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
6472 Bora PharmaceuticalsNT$182.0010.6%
+NT$1.2b
44.5%PE11.8x
6535 Lumosa TherapeuticsNT$38.55-0.8%
NT$378.5m
26.0%PE18.5x
6576 Foresee PharmaceuticalsNT$115.002.7%
+NT$352.7m
39.4%PS32.2x
6634 Sinew PharmaNT$82.302.2%
+NT$124.2m
3.9%PS1030.9x
1760 Panion & Bf BiotechNT$79.301.7%
+NT$111.5m
0.9%PE46.2x
Simply Wall Stâ„¢
Simply Wall Street Pty Ltd
17-21 Bellevue Street, Surry Hills, Sydney
Download on the App StoreGet it on Google Play
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News